ISIN | LU0401337042 |
---|---|
Valor Number | 4733493 |
Bloomberg Global ID | UBEOIAA LX |
Fund Name | UBS (Lux) Equity Fund - European Opportunity Sustainable (EUR) I-A2-acc |
Fund Provider |
UBS Asset Management Switzerland AG, Zurich
Basel, Switzerland Phone: +41 61 288 75 01 E-Mail: sh-ubs-funds-feedback@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG, Zurich |
Representative in Switzerland |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Distributor(s) |
UBS Global Asset Management Basel Phone: +41 61 288 20 20 |
Asset Class | Equities |
EFC Category | Equity Advanced Europe |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The Fund’s investment objective consists in generating strong capital appreciation with a reasonable level of income, while giving due consideration to capital security and the liquidity of the Fund’s assets. UBS Asset Management categorises this sub-fund as a Sustainability Focus Fund. This sub-fund promotes environmental and/or social characteristics and complies with Article 8 of Regulation (EU) 2019/2088 on sustainability-related disclosures in the financial services sector (“SFDR”). The actively managed sub-fund mainly invests in shares and other equity interests of companies that are domiciled or chiefly active in Europe. These investments may be complemented by shares and equity interest of companies that are domiciled or chiefly active outside of Europe. As part of this investment, the sub-fund may also invest directly or indirectly (i.e. up to 10% of the net assets in open-ended investment funds) in European small and/or mid caps. |
Peculiarities |
Current Price * | 232.56 EUR | 14.11.2024 |
---|---|---|
Previous Price * | 229.61 EUR | 13.11.2024 |
52 Week High * | 246.14 EUR | 30.08.2024 |
52 Week Low * | 216.03 EUR | 16.11.2023 |
NAV * | 232.56 EUR | 14.11.2024 |
Issue Price * | 232.56 EUR | 14.11.2024 |
Redemption Price * | 232.56 EUR | 14.11.2024 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 342,030,348 | |
Unit/Share Assets *** | 13,757,996 | |
Trading Information SIX |
YTD Performance | +3.99% |
29.12.2023 - 14.11.2024
29.12.2023 14.11.2024 |
---|---|---|
YTD Performance (in CHF) | +4.98% |
29.12.2023 - 14.11.2024
29.12.2023 14.11.2024 |
1 month | -4.61% |
14.10.2024 - 14.11.2024
14.10.2024 14.11.2024 |
3 months | -2.73% |
14.08.2024 - 14.11.2024
14.08.2024 14.11.2024 |
6 months | -3.97% |
14.05.2024 - 14.11.2024
14.05.2024 14.11.2024 |
1 year | +7.30% |
14.11.2023 - 14.11.2024
14.11.2023 14.11.2024 |
2 years | +16.04% |
14.11.2022 - 14.11.2024
14.11.2022 14.11.2024 |
3 years | -3.83% |
15.11.2021 - 14.11.2024
15.11.2021 14.11.2024 |
5 years | +34.29% |
14.11.2019 - 14.11.2024
14.11.2019 14.11.2024 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | 9.48 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date | 14.11.2024 |
Novartis AG Registered Shares | 4.66% | |
---|---|---|
ASML Holding NV | 4.32% | |
AstraZeneca PLC | 3.56% | |
Lvmh Moet Hennessy Louis Vuitton SE | 3.53% | |
Novo Nordisk AS Class B | 3.48% | |
Shell PLC | 3.28% | |
Danone SA | 3.21% | |
Ashtead Group PLC | 3.18% | |
HSBC Holdings PLC | 3.00% | |
Nestle SA | 2.99% | |
Last data update | 30.09.2024 |
TER | 0.69% |
---|---|
TER date | 30.11.2023 |
Performance Fee *** | 0.00% |
PTR | |
Max. Management Fee *** | 0.75% |
Ongoing Charges *** | 0.66% |
SRRI ***
|
|
SRRI date *** | 31.10.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |